Study of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to Treat Niemann-Pick Type C1 (NPC1) Disease

Condition:   Niemann-Pick Disease, Type CInterventions:   Drug: HP-β-CD;   Drug: Sham Procedure ControlSponsor:   Vtesse Inc.Not yet recruiting - verified August 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials